PCN68 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUXTM) FOR THE FIRST LINE TREATMENT OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN CANADA
May 1, 2009, 00:00
10.1016/S1098-3015(10)73305-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)73305-2/fulltext
Title :
PCN68 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUXTM) FOR THE FIRST LINE TREATMENT OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN CANADA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73305-2&doi=10.1016/S1098-3015(10)73305-2
First page :
Section Title :
Open access? :
No
Section Order :
733